H.C. Wainwright Downgrades CymaBay Therapeutic (CBAY) to Neutral
Tweet
Share
E-mailGet Alerts CBAY Hot Sheet
Price: $32.48 --0%
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 32
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 32
Join SI Premium – FREE
H.C. Wainwright analyst Ed Arce downgraded CymaBay Therapeutic (NASDAQ: CBAY) from Buy to Neutral.
For an analyst ratings summary and ratings history on CymaBay Therapeutic click here. For more ratings news on CymaBay Therapeutic click here.
Shares of CymaBay Therapeutic closed at $1.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Principal Financial Group (PFG) to Underperform
- Goldman Sachs Downgrades Inspur Electronic Information Industry Co Ltd (000977:CH) to Sell
- Raymond James Downgrades V2X, Inc. (VVX) to Market Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
H.C. Wainwright, Ed ArceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
